Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefprozil for Suspension

Approval Number

国药准字H20243606

Company金鸿药业股份有限公司拱北分公司

Registration Date

July 23, 2024

Drug Information

Generic Name

头孢丙烯干混悬剂

Dosage Form

口服混悬剂

Strength

0.25g（按C₁₈H₁₉N₃O₅S计）

Drug Type

化学药品

Registration Date

July 23, 2024

Company Information

Applicant Company

Company Name金鸿药业股份有限公司拱北分公司

Company Address

珠海市金海岸生物工业区

Manufacturing Company

Company Name金鸿药业股份有限公司拱北分公司

Company Address

珠海市金海岸生物工业区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy